NCT05880693View on ClinicalTrials.gov

Comparisons Between Dexmedetomidine and Magnesium Sulfate in Controlled Hypotension During Rhinoplasty Surgeries

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

April 1, 2023

Study Completion Date

May 1, 2023

Conditions
Hypotension
Interventions
DRUG

Dexmedetomidine

Group 1 received dexmedetomidine

DRUG

Magnesium sulfate

the group 2 received magnesium sulfate

Trial Locations (1)

Unknown

Mohamed gawad Abdel aboelsuod, Cairo

All Listed Sponsors
collaborator

Al-Azhar University

OTHER

lead

mohamed

OTHER

NCT05880693 - Comparisons Between Dexmedetomidine and Magnesium Sulfate in Controlled Hypotension During Rhinoplasty Surgeries | Biotech Hunter | Biotech Hunter